Last chance: Optimising expansion conditions for CAR-T cells
The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalised and potentially curative options.
But how can you enhance the characterisation and expansion of CAR-T cells and address ‘on target, off tumour’ effects?
Register now for this exclusive webinar ‘Characterisation of CAR-T cells: Integrating live-cell analysis and high-throughput cytometry’ on 5 December at 3pm GMT, which is supported by Sartorius.
In this event, Nicola Bevan, Manager of Cell Imaging Applications at Sartorius, will explore the functional characterisation of CAR-T cells and optimising CAR-T expansion processes. Through detailed case studies, the webinar will illustrate how these advanced techniques provide dynamic insights into CAR-T cell behaviour, tools for characterisation, and optimise expansion conditions.
With over 30 years of experience, Nicola is a highly skilled cellular pharmacologist. She has an extensive background in the pharmaceutical and biotech industries, where she has gained broad experience in large pharma industrial screening departments and the support of early drug discovery programmes.
What you will learn:
- About the functional characterisation of CAR-T cells
- Solutions for addressing ‘on target, off tumour’ effects
- Techniques for optimising CAR-T expansion including gaining dynamic insights into CAR-T cell behaviour, tools for characterisation, and methods for optimising expansion conditions
